Integrative Genomic Analysis Reveals Cancer-Associated Gene Mutations in Chronic Myeloid Leukemia Patients with Resistance or Intolerance to Tyrosine Kinase Inhibitor.

Moreover, the mutation rate of KIT in patients without ABL1 KD mutation was higher, but the difference did not reach statistical significance, which may have been due to the insufficient number of patients in this study.

also in 111,027 other papers